(("clinical guidelines"[Resource Type]) OR "practice guideline"[Public - Books - NCBI

Display Settings:

Summary

Format

Summary
Summary (text)

Send to:

Choose Destination

File
Clipboard
Collections
E-mail

Quoted phrase not found.
See the search details.

Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].

Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.

Search term

Table of contents

Select item 55148841.

Clinical Review.

Show details (2)

Supplemental Content

Related information

PMC
PubMed Central citations
PubMed
Links to PubMed

Search details

Recent activity

Clear Turn Off Turn On

(("clinical guidelines"[Resource Type]) OR "practice guideline"[P... (474)
(("clinical guidelines"[Resource Type]) OR "practice guideline"[Publication Type]) AND ("Malignant neoplasm of the central nervous system")
Search

Books
Rattus norvegicus SH3 and PX domains 2A (Sh3pxd2a), transcript variant 1, mRNA
Rattus norvegicus SH3 and PX domains 2A (Sh3pxd2a), transcript variant 1, mRNA
gi|2708422486|ref|NM_001107606.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...